Informed consent (IC) struggles to meet the ethical principles it strives to embody in the context of hematopoietic cell transplantation (HCT). Patients often participate in multiple clinical trials making it difficult to effectively inform the participants and fulfill complex regulations. The recent Notice of Proposed Rule Making would make major changes to federal requirements, providing a timely opportunity to evaluate existing practice. Twenty health care professionals within a Midwest Academic Medical Center involved in obtaining IC in the HCT clinic or involved in patient care during or after the IC process were interviewed to understand: (1) how they approached the IC process; (2) how they described a 'successful' IC process; and (3) opportunities for innovation. Narrative and discourse analyses of interviews indicate that providers understand IC to be a collaborative process requiring engagement and participation of providers, patients and caregivers. 'Markers of success' were identified including cognitive, affective and procedural markers focusing on patient understanding and comfort with the decision to participate. Opportunities for innovating the process included use of decision aids and tablet-based technology, and better use of patient portals. Our findings suggest specific interventions for the IC process that could support the process of consent for providers, patients and caregivers.
INTRODUCTION
Hematopoietic cell transplantation Hematopoietic cell transplantation (HCT) is a high-risk intervention for life-threatening cancer affecting patients and caregivers 1 that establishes immune function in patients with malignant and non-malignant conditions. 2 It is a complex procedure involving a number of decisions that are made by patients and their caregivers, including whether to participate in clinical research, that burden caregivers with emotional trauma and urgency to treat patients. 3 Caregivers require comprehensible information and good communication with their providers, as medically fragile patients undergoing HCT rely heavily on their caregivers in the decision-making process. 4, 5 In our previous work, we showed that patients consult with family caregivers to make difficult decisions. 5 Caregivers of patients undergoing HCT experience physical, psychological and social burden 6 while trying to maximize being informed and involved in the care of the patient to ensure coping, satisfaction with care, participation in decision making and adherence to physician recommendations. 4, [7] [8] [9] We have previously shown that although patients participated in clinical research primarily for altruism and benefits to society, they experienced difficulty in recalling information about specific studies, uncertainty about the burden associated with participation, and fear of personal harm. 5 A thorough and effective informed consent (IC) process is necessary to avoid potential feelings of regret from participation in clinical research studies. 10 Informed consent in HCT IC in HCT clinical research is a process central to the conduct of research that aims to protect human subjects. To live up to its ideal, the IC process significantly depends on good communication. 11 The IC process can be viewed as one that is conducive to shared decision-making, which has been linked to improved clinical outcomes. 12, 13 Consent is expected to describe the risks, benefits, rights and responsibilities of participants and researchers, and this information should be conveyed at a level such that the participants have a complete understanding. 14 However, the IC process often focuses on its documentation, which frequently includes long forms with legalistic language that are difficult to comprehend, [15] [16] [17] raising ethical concerns abut the effectiveness of informed consent to inform and provide an opportunity for research subjects to exercise autonomy. 18 In the context of HCT, this is a particularly urgent concern given that patients may be given numerous consent documents, including the standard of care as well as clinical research (observational or interventional), at one time. Moreover, each consent document is lengthy, resulting in significant information overload in an already stressful and overwhelming clinical situation.
The recent release of the Notice of Proposed Rulemaking in September 2015 further motivates our current study, particularly in light of its attempt to shorten and streamline the IC document to focus more specifically on essential information and supplementing additional information in an appendix. 19 Specifically, proposed changes to the Common Rule in the Notice of Proposed Rulemaking include stricter requirements regarding the information given to potential participants and the process by which informed consent is obtained. The goal of these changes is to ensure that potential participants are well informed about the study they are considering. To ensure the efficacy of these changes, it is necessary to understand the approach taken by providers who obtain IC, and further, to illuminate the facilitators and barriers to the current IC process as experienced by providers involved in HCT. By better understanding how providers and researchers approach the IC process, and how they describe a 'successful' IC process, our findings may inform the development and assessment of innovations in IC to improve patient experience and patient understanding of participation in clinical research studies. Specifically, our study was designed to better understand IC documentation and processes from the perspective of those gathering informed consent in the context of HCT. The goal of the research was to better understand how people involved in gathering informed consent (1) approach the IC process; (2) describe a 'successful' IC process; and (3) anticipate opportunities for innovating the IC process to better achieve its ethical goals.
20

MATERIALS AND METHODS
Data collection
We conducted semi-structured qualitative interviews with 20 health care professionals (providers) involved in obtaining informed consent or providers who interact with patients during or after the IC process in the HCT ambulatory care clinic at a Midwest academic medical center from October to November 2015. The study was granted permission with IRB exemption by the University of Michigan Institutional Review Board; thus, informed consent was not obtained from the study participants. Interview questions were developed around five topics that included (1) provider experiences with and approach to the current consent process; (2) markers of a successful IC process; (3) opinions on a supplementary short form presented to providers during the interview; (4) how to improve the IC process; and (5) perceptions of changes to the IC process that would improve or add unnecessary burden to the current process. This template was used for all interviews, with a total of 12 primary questions to address the five topic areas. Interviews were audio-recorded and professionally transcribed (Babbletype LLC, Philadelphia, PA, USA).
We interviewed the individuals involved in the research IC process in the HCT clinic as well as providers who interact with patients during or after the IC process, demonstrated in Figure 1 . We interviewed this particular group of individuals to gain insight into the experiences of key personnel involved during or after the consent process. Although all the participants are not necessarily involved directly in the process of obtaining consent from patients, our goal was to additionally illuminate the experience of providers whose interactions with patients are influenced by the IC process.
The study investigators contacted the participants by e-mail. The participants who were interviewed included physicians, nurse (RN) coordinators, social workers, psychologist, clinical research staff and the Institutional Review Board (IRB) committee members. The RN coordinators were interviewed because they are typically the first to provide information on clinical research studies to potential study participants, and they are present while the patient and caregiver read through the IC document and ask questions. The RN coordinator is also typically the witness to the patient's signature on the IC document. The physician may join to provide further information regarding the clinical research study or information about the IC document. Following this initial visit, patients proceed to their appointment with a social worker. We interviewed social workers who work closely with the HCT clinic. Finally, IRB and clinical research staff, including three Co-Chair faculty members of the IRB committee, were interviewed. Although not typically directly involved with patients, they were interviewed to provide further feedback on the current IC process and opportunities for improvement that are consistent with the ethical goals of informed consent. The research coordinator may, for example, follow up with the patient after their visit with an RN coordinator or physician to review components of the clinical research study, such as information about involvement of the study, participation and withdrawal from the study. The research coordinator then refers patients to the RN coordinator or physician for specific information about their medical care.
Data analysis
Transcribed interviews were reviewed by the Study Team (MR, SWC, and JP). A coding scheme was developed and interviews were coded to identify themes and patterns within and between provider categories. Narrative analysis was used to describe the experience of individuals, which could provide insight into how different providers approach and experience the gathering of informed consent. Narrative analysis is a qualitative analytical approach that aims to understand the experiences of participants with regard to a particular context 21 -in this case, the gathering of IC. Discourse analysis, which focuses on the use of language to reveal how an event is described, 22 was used to further evaluate the experience and process of informed consent. Discourse analysis enabled us to examine not only processes and culture, but also descriptors for what marks 'success' in obtaining informed consent by focusing on language as a structure based on the domains of life in which people take part, such as the medical domain. 23 
IRB
RESULTS
The response rate for participation in this qualitative research study was 95%. The participants who were interviewed included physicians (N = 2 HCT physicians, N = 1 psychiatrist), RN coordinators (N = 9), social workers (N = 2), psychologist (N = 1), clinical research staff (N = 2) and the IRB committee members (N = 3). Three major themes that emerged from this study included (1) how people involved in gathering informed consent approach the IC process; (2) how interviewees describe a 'successful' IC process; and (3) opportunities for innovating the IC process to better achieve its ethical goals (Table 1) .
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Provider experiences with and approach to the IC process RN coordinators described their role as presenting information, educating and acting as liaison. They expressed a desire for increased collaboration with the HCT physicians, for example, to help answer patient questions. They also described the use of informal decision aids (for example, post-it notes with summary information) to assist patients in reviewing consent material. Physicians valued giving patients time alone to contemplate participation. Physicians, clinical research coordinators and IRB staff emphasized the importance of ensuring patient understanding. Social workers expressed that the amount of information often overwhelmed patients. We identified two elements related to the IC approach, (a) reading; and (b) conversation/collaboration, that reflect the primary approaches providers adopted to engage patients during the IC process.
Reading. Allowing the patient to read was considered a first step in the IC process, wherein the provider would give the patient and caregiver the opportunity to read the IC document and contemplate questions. In the HCT clinic we studied, patients and caregivers were often sent home with IC documents to review overnight or until their next clinic visit. Notably, almost all interviewees considered this step in the process to be somewhat preliminary-that is, interviewees did not expect patients to understand what they read, but instead, considered this first read-through something of an 'orientation' to the study. It was, in a way, assumed that education and conversation would need to occur to thoroughly obtain informed consent.
Conversation and collaboration. Participants described the IC process as one that required face-to-face contact, involving conversation. Physicians, in particular, emphasized the importance of open discourse and collaboration:
'I think it's about creating that environment, where it's okay for the patient to feel open to discussion of their own conceptualization, their own process and their own frustrations with whatever is going on.' (Physician)
All interviewees described a process in which they would verbally provide the patient with necessary information enabling them to make an independent decision, under the assumption that patients might not read through hundreds of pages on their own. Moreover, conversation was highlighted as a technique that can empower patients to make a decision because it provides an opportunity to ask questions and present concerns.
One component of 'conversation' that was salient in interviews was the idea of educating patients. That is, providers described the importance of not only responding to patients' questions, but to also educate them by explaining, and sometimes even offering them ideas of questions they might want to ask their physician. The process of educating patients was facilitated by an informal decision aid (post-it notes and labels) developed by nurse coordinators, providing summaries of major sections of the IC document. These summaries were utilized as primary teaching points as well.
Finally, interviewees described the importance of providers collaborating with each other to ensure complete patient understanding. Therefore, in cases where patients were unable to make a decision based on just the nurse coordinator's education and consultation, the physician was requested to meet with the patient as well. However, RN coordinators expressed that it would be comforting to patients if RN coordinators and physicians were able to collaboratively consult with all the patients.
Markers of a 'successful' IC process The participants described a 'successful' IC process in ways that included patient comfort with decisions, engagement, support for research goals, and understanding of content and information recall. Obtaining a signature was considered a marker of success for some, but most recognized that this did not capture comprehension or quality, which were considered critical to meeting ethical goals of informed consent. Physicians particularly emphasized patient engagement and ability to recall learned information. IRB staff described 'success' as patients having a complete understanding, especially of risks and benefits. Interviewees described three types of markers of success: (a) cognitive (that is, patient understanding and recall of information); (b) affective (that is, patient comfort and provider confidence in decision); and (c) procedural.
Cognitive markers of success. Understanding-Patient understanding was considered a key marker of success. Physicians and nurses conveyed that without understanding, an IC process could not, in fact, be 'informed'. However, it is not always easy to gauge patient understanding, particularly because patients are often overwhelmed with the amount of information given to them in a short amount of time. For example, participants reflected that patients might not immediately identify their questions or concerns, therefore, believing that they have a complete understanding. This temporal aspect in combination with an overload of information makes it challenging to precisely measure understanding. Recall of information-A frequently cited way of evaluating a patient's level of understanding was by assessing a patient's recall of information, that is, asking questions of the patient, and assessing their level of understanding on the basis of how much information they could repeat back to the provider (Table 2) . Interviewees described recall of information as being a particularly salient measure of patient understanding; but physicians described concern that measuring recall was potentially not practiced as often as it should be ( Table 2 ).
Although providers who described assessing recall of information described it as being much like a 'conversation' or 'like a quiz', interviewees discussed the potential for innovations through technology and decision aids to ensure understanding and more formally measure recall of information. These innovations will be described later in our results.
Affective markers of success. Comfort with decision-Another way that interviewees described a successful consent process, was through the idea that patients should be comfortable with their decision to participate (or not participate) in a clinical research study. This was discussed in a few ways: (1) engagement, described by interviewees as instances where patients would be involved in discussion and dialog with providers, in particular by asking questions and offering their own perspectives, could ultimately strengthen shared decision-making (Table 2) ; (2) providers giving patients the opportunity to engage was also described as a nuance that results in 'comfort with decision' because patients were perceived to have more trust in their provider to act in their best interest (Table 2); (3) another interesting facet of 'comfort with decision' was the idea of 'engagement' actually plateauing; similar to reaching a point of saturation, when a decision is made. This process was described as engagement that resulted in confidence in the decision, and thus, closure (Table 2) ; (4) finally, interviewees pointed to examples of patients who are engaged in the decision-making process by reflecting on what participation in clinical research studies achieves. This idea of altruism was categorized as engagement because it was described as a realization reached upon completion of the informed consent, wherein patients realized that although they may not directly benefit from the clinical research study, they could help others. Provider confidence-Although not specifically related to patient comfort with decision, an interesting complement to patient comfort was the notion of provider confidence. Similar to what was described earlier in terms of patients reaching a concrete decision, interviewees described that the provider team has to experience closure and a definitive decision as well. Signature 'If they sign and I get them done and sent to where they're supposed to be I feel success…getting them all done, getting them all in…' (nurse coordinator) '…having them sign their name, I don't feel like that's something that's necessary to make it successful.' (RN coordinator)
Abbreviation: RN = registered nurse.
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Procedural markers of success. Noting the time constraints in health care delivery, and the overwhelming number of consent documents that must be presented to the patients, those involved in gathering informed consent looked to procedural markers to describe a successful IC process but often found them lacking in practice. Interviewees described the IC process as being so overwhelming that its value ultimately diminishes to merely obtaining a signature from a patient. In other words, simply finishing the process was considered a marker of success. Only one interviewee described a signature as being the only marker of success; most interviewees described that there are multiple markers of success beyond a signature, such as patient understanding, recall of information, patient engagement and comfort with decision.
Opportunities for improvement and innovation in the IC process Informal decision aids. Providers discussed tools that they have developed over time in their role to assist them in facilitating the IC process, as well as ideas that were conveyed to us during interviews, as potentially transforming the IC process and benefiting patients. As described above, the RN coordinators in particular described their use of informal artifacts to assist the patients in reviewing consent material. They described writing key pieces of information from each section of the original IC document on separate post-it notes or labels, and then attaching these to the beginning of relevant sections of the actual document. During consultation with the patients, these 'summary labels' would be presented to the patients before or subsequent to patients' individual reading of the document. The patients would then be able to ask more specific questions as needed. A representative quote is provided in Table 3 , quotation 1. All interviewees supported the use of a decision aid that summarizes important components of IC documents to help patients navigate information while still having access to the original document for greater detail. We presented interviewees with a 'short form' decision aid as shown in Platt et al. 17 that could be used as a tool to guide decision-making during the IC process and help patients and caregivers find the information they need most. Interviewees were generally optimistic that such an instrument would encapsulate the self-described 'necessary components' for patient comprehension: (1) understanding of content; (2) understanding of alternatives/options; (3) understanding of risks and benefit; (4) understanding of time commitment; and (5) understanding that participation is voluntary. Those using the informal decision aids described above viewed the short form as a more formalized and integrative tool for steps they were already taking to make the IC process more accessible.
Technology. All interviewees were asked about, and described, the potential for technology to assist in conveying meaningful information to patients through interactive education by, for example, use of tablet technology or integration of the consent document onto patient portals to be read through ahead of time and accessed as needed. Technology was perceived as a way to increase patient access to information about the study even outside of the clinic, and was also described as a means to make information more comprehensible to patients (Table 3,  quotation 2) . Tablet technology was also described as presenting an opportunity to demonstrate recall of information. Through technology, the physician would not have to judge true patient understanding simply based on a response of 'yes'. Linking to the previously mentioned idea of asking patients questions, almost in the format of a 'quiz', tablets were described has having the capacity to do this interactively (Table 3, quotation 3) .
However, some were reluctant to integrate consent forms into patient portals, concerned that it would simply provide access to an overwhelming document and not be of service, and furthermore, that some patients may not have access to the technology. Moreover, interviewees who supported the use of tablets expressed concerns inherent to reading any document on technology (Table 3 , quotation 4). Most interviewees commented that the face-to-face visit between the patient and provider was imperative, and would be an aspect of the IC process that should be maintained regardless of the implementation of technology.
DISCUSSION
Our study findings suggest that it is essential for providers to continuously assess and measure proposed markers of success to ensure a consent process that truly serves its purpose. Herein, a majority of the interviewees described that there are multiple markers of success beyond a signature, such as patient understanding, recall of information, patient engagement and comfort with decision. Accordingly, there is a need for better alignment of IC policy, process and practice to address these challenges of informed consent in HCT. That is, for proposed policy changes to be efficacious, the way in which informed consent in HCT is obtained in practice needs to be modified.
Addressing current ethical challenges of informed consent in HCT The current IC process poses an ethical challenge such that the patients are not truly informed of the possible risks, benefits and aspects of participation such as time burden. This could result in false expectations or misunderstanding of information, 24 or lack of patient autonomy owing to an inability to make a knowledgeable decision. 25 The potential for regret, reduced quality of life, or negative consequences due to inadequate information before making a decision about participation is an ethical challenge that must be addressed.
Renewed focus on the IC process as an interaction between patients, caregivers and providers could increase its effectiveness as an educational and informative part of research. In the Informal decision aids 1. '…Just a little sticky note on the front just to give the patient an idea of what this is about, and to encourage them to read on further. Almost to entice them to say oh, look at this.' (RN coordinator) Technology 2. 'If you have two pictographs together…you can clearly see the differences between risks and benefits, even if you don't understand the numbers…On an iPad…maybe there's a question mark you click on and it goes to a hyperlink and tells you more about it' (IRB committee member) 3. 'The nice thing about using iPads is you can build in quizzes…like games… You can get a sense of their understanding as they're doing it.' (IRB committee member) 4. '…I think it can be hit or miss because I've had people read consents on computers and just scroll right through.' (Research Assistant)
Informed consent process in HCT M Raj et al experience of our interviewees, providing patients and caregivers sufficient time and space for reading and reflection, if not comprehension, is valued. In the clinical setting, comprehension could be better ensured by focusing on consent as a shared decision-making process; that is, a process that encompasses the sharing of information between provider(s) and patient, followed by an agreement on the next course of action 26 -in this case, participation in a clinical research study. Further examination of how clinical teams work together with patients and caregivers could support comprehension, shared decision-making, and patient and provider satisfaction. Coordination across providers within a given clinical setting should be examined carefully as well as shared decision-making between patients and providers. Although not examined in this study, it is possible that patients are able to perceive when their provider team is not settled on a decision, and this may lead to further patient discomfort with their decision as well. Recognizing that time and resource constraints may limit these interactions between physician and patient, more innovative strategies may be needed to facilitate this process.
Potential use of technology and decision aids in the HCT IC process Use of technology, supplementary decision aids, as well as conversation and collaboration throughout the IC process may further increase opportunities for providers to engage patients and caregivers to optimize patient decision-making. Technology, such as consent videos that show IC information, have been demonstrated as improving information recall and retention. 27 For example, cognitive markers of success might be assessed through patient recall on tablet-based 'quizzes', and the use of interactive technology such as tablets have been suggested to improve comprehension as well as satisfaction. 28 Providers can thus focus on misinformation in need of further explanation. Decision aids, such as the supplementary short form, have been suggested to improve knowledge and retention of information in patients contemplating participation in clinical research studies, thereby also reducing regret. 10, 29 Even with supplementary decision aids and use of technology as well as patient portals, our research suggests, and the literature supports, that the face-to-face conversation is a cornerstone of the IC process. 30 Modifying and evaluating goals of informed consent When the IC process focuses on merely obtaining a signature, time and energy are invested in that end goal. The signature is a documentation of consent, not a representation of comprehension and engagement that embody the ethical principles of informed consent. Our findings suggest that modifying goals of the process such that the focus is on education, could guide the gathering of a more ethical, comprehensible consent.
Current procedural requirements, such as obtaining a signature were generally viewed as inadequately reflecting the value of informed consent and failing to reflect true informed consent of the patient. Evaluative markers such as providers specifically assessing patient comfort and confidence with participation might improve consent protocols to better document their effectiveness. Such procedural improvements can be flexible and largely independent of changes to required documentation and to policy changes such as those proposed for the Common Rule or local institutional requirements. By the same token, changes to the Common Rule will force an overall reexamination of existing policies and practices providing an opportunity to integrate new tools that can support meeting the goals of informed consent.
Limitations and future directions. Our study addresses a gap in the literature by examining the perspective of health care providers and clinical research staff on the IC process; however, patient perspectives should be included in future studies. We hope that by gaining in-depth insights into provider experiences, we will be able to make recommendations that can be addressed on a structural level (at all levels of the health care system). In the future, additional interview questions and observations may be conducted to illuminate the experience of providers and researchers consulting on informed consent for clinical studies with a broader scope of patients. In addition, our sample size was small, including 20 participants, specifically in the blood and marrow transplantation context at a single institution. However, our sample was robust in its inclusion of pediatric and adult physicians as well as RN coordinators.
In conclusion, it is important that the concept of informed consent does not lose itself in the complexities of a paper form or legal document, particularly for the blood and marrow transplantation patients and caregivers who already find themselves facing fragile medical conditions. Instead, informed consent should increasingly be recognized among providers as an iterative process that is critical for and closely linked to patient safety and quality of care and the process is continuously improved upon over time.
